7
Total investments
0
Early stage
0
Mid stage
1
Late stage
31y
Years active
Portfolio
2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Jun 2014
We are focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy. We are committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials.
Please see our social media community guidelines at http://bit.ly/1UVcx0L
Board Member
2012
Sonendo® is a leading dental technology company focused on saving teeth from tooth decay, the most prevalent chronic disease globally. This is evident in the technology driving our flagship innovation: The GentleWave® System.
Over 1 Million Patients have been treated with the GentleWave Procedure. It is designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The system utilizes a proprietary mechanism of action, which combines procedure fluid optimization, broad-spectrum acoustic energy, and advanced fluid dynamics, to debride and disinfect deep regions of the complex root canal system in a less invasive procedure that preserves tooth structure.
The clinical benefits of the GentleWave System include improved clinical outcomes, such as deeper cleaning that is independent of root canal complexity and tooth anatomy, high and rapid rates of healing and minimal to no post-operative pain. In addition, the GentleWave System can improve the workflow and economics of dental practices. The CleanFlow™ procedure instrument is designed to work with Sonendo's GentleWave System to improve efficiencies for doctors and the overall experience for patients.
Sonendo is also the parent company of TDO® Software, the developer of widely used endodontic practice management software solutions, designed to simplify practice workflow. TDO Software integrates practice management, imaging, referral reporting and CBCT imaging, and offers built-in communication with the GentleWave System.
At Sonendo, we are dedicated to supporting practices with innovation designed to improve the patient experience and maximize clinical efficacy, procedure efficiency, and practice economy.
Experience · 8 entries
All (8)
Investments (7)
Board (6)
2017
Board Member
Jul 2017
The RNS® System is an award-winning technology developed and manufactured in Silicon Valley that has been recognized for its innovation. Similar to a pacemaker that monitors and responds to heart rhythms, the RNS System is the worlds first and only medical device that can monitor and respond to brain activity.
NeuroPace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders with responsive stimulation. The companys initial focus is the treatment of epilepsy, a debilitating neurological disorder affecting approximately 1% of the population worldwide.In addition to treating epilepsy, responsive neurostimulation holds the promise of treating several other disabling medical disorders that impact the quality of life for millions of patients around the world.
2016
C
Cryterion Medical, Inc.
Board Member
Oct 2016
2014
Board Member
Jun 2014
We are focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy. We are committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials.
Please see our social media community guidelines at http://bit.ly/1UVcx0L
2012
V
Vessix Vascular
Board Member
2012
Board Member
2012
Sonendo® is a leading dental technology company focused on saving teeth from tooth decay, the most prevalent chronic disease globally. This is evident in the technology driving our flagship innovation: The GentleWave® System.
Over 1 Million Patients have been treated with the GentleWave Procedure. It is designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The system utilizes a proprietary mechanism of action, which combines procedure fluid optimization, broad-spectrum acoustic energy, and advanced fluid dynamics, to debride and disinfect deep regions of the complex root canal system in a less invasive procedure that preserves tooth structure.
The clinical benefits of the GentleWave System include improved clinical outcomes, such as deeper cleaning that is independent of root canal complexity and tooth anatomy, high and rapid rates of healing and minimal to no post-operative pain. In addition, the GentleWave System can improve the workflow and economics of dental practices. The CleanFlow™ procedure instrument is designed to work with Sonendo's GentleWave System to improve efficiencies for doctors and the overall experience for patients.
Sonendo is also the parent company of TDO® Software, the developer of widely used endodontic practice management software solutions, designed to simplify practice workflow. TDO Software integrates practice management, imaging, referral reporting and CBCT imaging, and offers built-in communication with the GentleWave System.
At Sonendo, we are dedicated to supporting practices with innovation designed to improve the patient experience and maximize clinical efficacy, procedure efficiency, and practice economy.
Show all 8 entries ↓
Investment activity
1995–2017 · 7 investments
Recent (last 2 years)Earlier
